A Phase II, Open-Label, Single Arm Trial to Assess the Efficacy and Safety of the Combination of Tisagenlecleucel and Ibrutinib in Mantle Cell Lymphoma (TARMAC)

被引：4
|
作者：
Minson, Adrian
Hamad, Nada
Butler, Jason P.
Westerman, David Alan
Ritchie, David
Blombery, Piers
Seymour, John F.
Tam, Constantine S.
Dickinson, Michael
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138946
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter Open-Label, Single-Arm, Phase II Trial
    Gine, Eva
    de la Cruz, Fatima
    Jimenez Ubieto, Ana
    Lopez Jimenez, Javier
    Martin Garcia-Sancho, Alejandro
    Jose Terol, M.
    Gonzalez Barca, Eva
    Casanova, Maria
    de la Fuente, Adolfo
    Marin-Niebla, Ana
    Muntanola, Ana
    Jose Gonzalez-Lopez, Tomas
    Aymerich, Marta
    Setoain, Xavier
    Cortes-Romera, Montserrat
    Rotger, Amanda
    Rodriguez, Sonia
    Medina Herrera, Alejandro
    Garcia Sanz, Ramon
    Nadeu, Ferran
    Bea, Silvia
    Campo, Elias
    Lopez-Guillermo, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (11) : 1196 - +
  • [2] Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial
    Wang, Michael L.
    Lee, Hun
    Chuang, Hubert
    Wagner-Bartak, Nicolaus
    Hagemeister, Frederick
    Westin, Jason
    Fayad, Luis
    Samaniego, Felipe
    Turturro, Francesco
    Oki, Yasuhiro
    Chen, Wendy
    Badillo, Maria
    Nomie, Krystle
    DeLa Rosa, Maria
    Zhao, Donglu
    Lam, Laura
    Addison, Alicia
    Zhang, Hui
    Young, Ken H.
    Li, Shaoying
    Santos, David
    Medeiros, L. Jeffrey
    Champlin, Richard
    Romaguera, Jorge
    Zhang, Leo
    LANCET ONCOLOGY, 2016, 17 (01): : 48 - 56
  • [3] Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial
    Jerkeman, Mats
    Eskelund, Christian Winther
    Hutchings, Martin
    Raty, Riikka
    Wader, Karin Fahl
    Laurell, Anna
    Toldbod, Helle
    Pedersen, Lone Bredo
    Niemann, Carsten Utoft
    Dahl, Christina
    Kuitunen, Hanne
    Geisler, Christian H.
    Gronbaek, Kirsten
    Kolstad, Arne
    LANCET HAEMATOLOGY, 2018, 5 (03): : E109 - E116
  • [4] Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
    Mokdad, Ali A.
    Zhu, Hao
    Beg, Muhammad S.
    Arriaga, Yull
    Dowell, Jonathan E.
    Singal, Amit G.
    Yopp, Adam C.
    TARGETED ONCOLOGY, 2019, 14 (05) : 541 - 550
  • [5] Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
    Ali A. Mokdad
    Hao Zhu
    Muhammad S. Beg
    Yull Arriaga
    Jonathan E. Dowell
    Amit G. Singal
    Adam C. Yopp
    Targeted Oncology, 2019, 14 : 541 - 550
  • [6] Efficacy and safety of endostatin in combination with chemotherapy in small cell lung cancer: a phase 2 single-arm multicenter open-label trial
    Zhao, Yi
    Zhang, Xu
    Jin, Chenxing
    Yu, Xiaomin
    Zhang, Min
    Cao, Yang
    Li, Ying
    Wang, Aman
    Shan, Xiu
    Zhang, Jia
    Wang, Juhong
    Yin, Liu
    Tan, Xiaoxin
    Liu, Jiwei
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (03) : 3277 - 3285
  • [7] Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma
    Kilgour, James M.
    Shah, Aatman
    Urman, Nicole M.
    Eichstadt, Shaundra
    Do, Hanh N.
    Bailey, Irene
    Mirza, Amar
    Li, Shufeng
    Oro, Anthony E.
    Aasi, Sumaira Z.
    Sarin, Kavita Y.
    CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4717 - 4725
  • [8] An open label, single arm, multicenter phase II study of the efficacy and safety of LP-168 monotherapy for relapsed or refractory mantle cell lymphoma.
    Song, Yuqin
    Tang, Xiaoqiong
    Cai, Qingqing
    Liu, Lihong
    Jing, Hongmei
    Jiang, Ming
    Sun, Xiuhua
    Wu, Jianqiu
    Yang, Yu
    Wu, Huijing
    Peng, Zhigang
    Ding, Kaiyang
    Yi, Shuhua
    Yan, Xiaojing
    Wu, Guowu
    Wu, Yudan
    Cui, Jie
    Ou, Pengju
    Tan, Fenlai
    Zhu, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] ELARA: A phase II, single-arm, multicenter, open label trial investigating the efficacy and safety of tisagenlecleucel in adult patients with refractory/relapsed follicular lymphoma (r/r FL).
    Dickinson, Michael
    Popplewell, Leslie
    Kolstad, Arne
    Ho, Joy
    Teshima, Takanori
    Dreyling, Martin H.
    Schuster, Stephen J.
    Thieblemont, Catherine
    Yateman, Nigel
    Lehnhoff, Katja
    Lawniczek, Tomasz
    Bubuteishvili-Pacaud, Lida
    Fowler, Nathan Hale
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study
    Song, Yuqin
    Song, Yongping
    Liu, Lihong
    Zhang, Mingzhi
    Li, Zhiming
    Ji, Chunyan
    Xu, Wei
    Liu, Ting
    Xu, Bing
    Wang, Xin
    Gao, Sujun
    Zhang, Huilai
    Hu, Yu
    Li, Yan
    Cheng, Ying
    Yang, Haiyan
    Cao, Junning
    Zhu, Zunmin
    Hu, Jianda
    Zhang, Wei
    Jing, Hongmei
    Ding, Kaiyang
    Lu, Zhengguang
    Zhang, Bin
    Zhao, Renbin
    Xu, Zhixin
    Zhu, Jun
    BLOOD, 2019, 134
12345